MedPath

Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease

Not Applicable
Completed
Conditions
Recurrent Pilonidal Sinus Disease
Registration Number
NCT02287935
Lead Sponsor
Adana Numune Training and Research Hospital
Brief Summary

It was investigated whether there is a factor that can aid determination of the preferred technique by comparing the early Limberg flap and Karydakis procedure techniques for the treatment of recurrent pilonidal sinus.

Detailed Description

Sacrococcygeal pilonidal sinus is common in young men and may recur overtime after surgery.

It was investigated whether there is a factor that can aid determination of the preferred technique by comparing the early Limberg flap and Karydakis procedure techniques for the treatment of recurrent pilonidal sinus.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  1. Patients willing to give written informed consent

  2. There should be recurrent pilonidal sinus

  3. Recurrent adult patients (over 18 years of age) undergoing surgery for pilonidal sinus

  4. International normalizing ratio (INR) less than 1.5

  5. Prothrombin time (PT) should be less than 15 s

  6. Partial thromboplastin (PTT) time should be near normal

  7. Platelet count should be greater than 50,000 per mm3 to limit the risk of bleeding

  8. There must be no infection at the time of surgery

Exclusion Criteria
  1. Patients not willing to give informed consent

  2. Age less than 16 years

  3. Patient presenting with conditions mimicking pilonidal sinus

  4. Diabetes mellitus, renal failure, immunosuppression e.g. were excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Superiority of Limberg Flap in Recurrent Pilonidal Sinus DiseaseJanuary 2009 to December 2013, Patients were invited for control 1 month, 3 months, 6 months, 1 year intervals

Superiority as measured by rates of recurrence and complication, length of hospital stay, return work, VAS skore, patient satisfaction and complet healing duration.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.